Omar Magid

Omar Magid has a diverse work experience in the field of research and development. Omar is currently working as a Principal Research Associate at Exo Therapeutics since February 2021. Prior to that, they worked at Proteostasis Therapeutics, Inc. from September 2016 to August 2020, where they served as a Cell Culture Specialist, Biosafety Officer, and Lab Manager. In this role, they maintained cell cultures and grew human bronchial epithelial cells (HBEs) and induced pluripotent stem cells (iPS Cells).

Before joining Proteostasis Therapeutics, Omar worked as a Research Associate (Temp) at BioLegend from March 2016 to August 2016. Here, they joined the neurodegenerative disease group and focused on identifying a biomarker for Parkinson's disease. Omar evaluated the presence of alpha-synuclein protein in CSF samples using various assays.

In 2015, Omar worked as a Senior Research Associate (Temp) at FORMA Therapeutics, Inc., where they established and managed a central cell bank for the entire company. Omar expanded and banked approximately 200 cell lines during their tenure.

Prior to that, Omar worked as a Sr. Research Associate (Temp.) at Genocea Biosciences from June 2012 to August 2013. In this role, they performed high-throughput DNA extraction and conducted quantitative real-time PCR. Omar also authored protocols for both DNA extraction and PCR.

From March 2010 to April 2012, Omar worked as a Scientific Associate II (Temp.) at Novartis Institutes for BioMedical Research. Here, they established a stock of cell lines for the department and developed cellular assays used for compound efficacy profiling. Omar gained experience with automated liquid handling equipment.

Omar's early work experience includes working as a Senior Screening Specialist (combination HTS) at CombinatoRx, Inc. (currently Horizon CombinatoRx) from June 2001 to April 2008. Omar has extensive experience with mammalian cell culture and has developed and executed various oncology cell-based and biochemical assays using immunoassays such as ECL, DELFIA TRF, and HTRF.

Omar Magid attended Boston University from 1989 to 1993. During this time, they pursued a Bachelor of Science degree in Biomedical Laboratory and Clinical Sciences.